Green Thumb Industries (GTBIF) Total Liabilities (2019 - 2026)
Green Thumb Industries (GTBIF) posted Total Liabilities of $934.6 million for Q1 2026, up 6.27% on a QoQ basis from $879.4 million in Q4 2025, and up 22.53% year-over-year from $762.7 million in Q1 2025.
Green Thumb Industries (GTBIF) Total Liabilities (2019 - 2026) Analysis & Trends
Green Thumb Industries' Total Liabilities history runs 8 years deep, the most recent figure standing at $934.6 million for Q1 2026.
- Quarterly Total Liabilities rose 22.53% year-over-year to $934.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $934.6 million (up 22.53% YoY) and the FY2025 annual result came in at $879.4 million, up 17.58% from the prior year.
- Total Liabilities was $934.6 million for Q1 2026 at Green Thumb Industries, up from $879.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $934.6 million in Q1 2026 and bottomed at $740.2 million in Q3 2024.
- A 5-year average of $789.3 million and a median of $786.6 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 66.27% — and 2024, when it declined 6.58%.
- Green Thumb Industries' Total Liabilities stood at $768.1 million in 2022, then climbed by 2.44% to $786.8 million in 2023, then slipped by 4.94% to $747.9 million in 2024, then grew by 17.58% to $879.4 million in 2025, then increased by 6.27% to $934.6 million in 2026.
- Business Quant data shows GTBIF's Total Liabilities at $934.6 million in Q1 2026, $879.4 million in Q4 2025, and $804.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 934.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 934.56 Mn |
| Dec 31, 2025 | 879.41 Mn |
| Sep 30, 2025 | 804.28 Mn |
| Jun 30, 2025 | 748.82 Mn |
| Mar 31, 2025 | 762.74 Mn |
| Dec 31, 2024 | 747.93 Mn |
| Sep 30, 2024 | 740.15 Mn |
| Jun 30, 2024 | 786.60 Mn |
| Mar 31, 2024 | 807.69 Mn |
| Dec 31, 2023 | 786.80 Mn |
| Sep 30, 2023 | 792.31 Mn |
| Jun 30, 2023 | 807.02 Mn |
| Mar 31, 2023 | 812.02 Mn |
| Dec 31, 2022 | 768.10 Mn |
| Sep 30, 2022 | 749.07 Mn |
| Jun 30, 2022 | 748.35 Mn |
| Mar 31, 2022 | 742.16 Mn |
| Dec 31, 2021 | 766.37 Mn |
| Sep 30, 2021 | 705.31 Mn |
| Jun 30, 2021 | 563.48 Mn |